The UK FTSE 100 index has recently declined following weak trade data from China, yet high-growth tech stocks continue to thrive, particularly Nexxen International Ltd., which reported a significant turnaround in Q2 sales and profits. Investors are advised to consider UK companies that align with Warren Buffett's investment philosophy, with Admiral insurance being highlighted for its superior business quality. AstraZeneca is also noted as a potential leader in the upcoming bull market, with ambitious revenue growth targets and strategic acquisitions to enhance its portfolio. Meanwhile, Rolls-Royce, despite a strong past year, may not sustain its growth momentum, prompting analysts to seek alternative growth prospects. Additionally, a new investment strategy termed 'Granolas' has surfaced, focusing on a group of European multinationals, including AstraZeneca, known for their solid fundamentals and dividends, suggesting diversification may mitigate risks in current market conditions.